Glucagon-like peptide-1 receptor agonists in patients with anthracycline related cardiac dysfunction

Abstract Background Cancer therapy-related cardiac dysfunction (CTRCD) is recognized complication of antineoplastic therapies, and is particularly associated with anthracyclines. Treatment revolves around heart failure management, with limited evidence for other medications. Specifically, the aim of...

Full description

Bibliographic Details

Published in:	Cardio-Oncology
Main Authors:	Isabel G. Scalia, Ramzi Ibrahim, Mahmoud Abdelnabi, Hoang Nhat Pham, Juan M. Farina, Milagros Pereyra Pietri, Kwan S. Lee, Balaji K. Tamarappoo, Reza Arsanjani, Chadi Ayoub
Format:	Article
Language:	English
Published:	BMC 2025-09-01
Subjects:	Glucagon-like peptide-1 receptor agonists Anthracycline chemotherapy Cancer therapy-related cardiac dysfunction
Online Access:	https://doi.org/10.1186/s40959-025-00381-y